Art

J-GLOBAL ID：201402209112705757   Reference number：14A0272599

Fibroblast Growth Factor-5 Participates in the Progression of Hepatic Fibrosis

線維芽細胞増殖因子-5が肝線維症の進行に関係する

Author (8)： HANAKA Hiromi (Dep. of Developmental Anatomy and Regenerative Biology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa ...) ,  HAMADA Tsuyoshi (Dep. of Anatomy and Neurobiology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa, Saitama 359-8513, JPN) ,  ITO Masataka (Dep. of Developmental Anatomy and Regenerative Biology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa ...) ,  NAKASHIMA Hiroyuki (Dep. of Immunology and Microbiology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa, Saitama 359-8513, JPN) ,  TOMITA Kengo (Div. of Gastroenterology and Hepatology, Dep. of Internal Medicine, National Defense Medical Coll., 3-2 Namiki ...) ,  SEKI Shuhji (Dep. of Immunology and Microbiology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa, Saitama 359-8513, JPN) ,  KOBAYASHI Yasushi (Dep. of Anatomy and Neurobiology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa, Saitama 359-8513, JPN) ,  IMAKI Junko (Dep. of Developmental Anatomy and Regenerative Biology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa ...)
Material： Experimental Animals  (実験動物ニュース)
Volume： 63  Issue： 1  Page： 85-92 (J-STAGE)  Publication year： 2014 
JST Material Number： Z0755A  ISSN： 1341-1357  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： Mus musculus ,...
Semi thesaurus term： histopathology ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0272599&from=J-GLOBAL&jstjournalNo=Z0755A") }}

JST classification (3)： Basic medicine on digestive system  (GH01020E) ,  Liver  (EJ06060J) ,  Biological function  (EB03040U)

Reference (24)：

• 1. Afdhal N.H. 2012. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? JAMA. 308: 608-616.
• 2. Allerstorfer S., Sonvilla G., Fischer H., Spiegl-Kreinecker S., Gauglhofer C., Setinek U., Czech T., Marosi C., Buchroithner J., Pichler J., Silye R., Mohr T., Holzmann K., Grasl-Kraupp B., Marian B., Grusch M., Fischer J., Micksche M., and Berger W. 2008. FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene 27: 4180-4190.
• 3. Angulo P., Keach J.C., Batts K.P., and Lindor K.D. 1999. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362.
• 4. Bacon B.R., Farahvash M.J., Janney C.G., and Neuschwander-Tetri B.A. 1994. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103-1109.
• 5. Bieghs V., van Gorp P.J., Walenbergh S.M., Gijbels M.J., Verheyen F., Buurman W.A., Briles D.E., Hofker M.H., Binder C.J., and Shiri-Sverdlov R. 2012. Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology 56: 894-903.

Terms in the title (2)： 線維芽細胞増殖因子 ,  肝線維症